End stage renal disease or chronic kidney disease. Chronic kidney disease, stage 5
Conditions
Interventions
Intervention 1: Intervention group: In the intervention group, simultaneously with the treatment of chronic kidney diseases and dialysis ,zinc sulfate tablets will be prescribed for 3 months.Treatme
Sponsors
Shahroud University of Medical Sciences
Eligibility
Sex/Gender
All
Age
15 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients are under hemodialysis for at least 4 months Have the power to understand and sign the informed consent form Age over 15 years old Body mass index between 20 to 35 Serum calcium levels above 7.5 mg / dl Serum phosphorus levels below 5 mg / dl Hemoglobin levels range from 9 to 12 g / dl Non-Depression Detection Absence of depression confirmed by the doctor
Exclusion criteria
Exclusion criteria: Zinc sulfate is susceptible Use zinc sulfate before entering the study Malignancy at present Hyperparathyroidism at present Use of depression drugs Infected with active infection
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Dialysis adequacy. Timepoint: Beginning of the intervention (before the intervention), Monthly up to 6 months after the start of the study. Method of measurement: Blood tests and calculations of urea and creatinine in blood tests, Calculate the duration of dialysis, measure the weight of patients. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Mohammad teymori
Shahroud University of Medical Sciences
Outcome results
None listed